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Giardia  lamblia  is an anaerobic flagellated protozoa and a common inhabitant 
of human intestine.  It is transmitted  mainly by ingestion of the cysts in contami- 
nated food or drinking water, and is present in at least 10% of the population in 
the United States (1). The infection causes diarrhea, abdominal pain, weight loss, 
and retarded growth in children. Tbe infectious dose of cysts appears to be quite 
low,  whereas  a  large  number  of cysts can  be shed  from  infected  individuals. 
Metronidazole (Flagyl) and atabrine are the only two drugs available for treating 
the  infection;  both  having  undesirable  side effects (2).  No  chemoprophylactic 
drugs are yet available for giardiasis. 
Recent success in establishing axenic cultures of G. lamblia trophozoites (3) has 
made it possible to study the metabolisms in this organism.  In one recent report 
(4), G. lamblia was found incapable of incorporating orotic and aspartic acid into 
nucleic acids,  and  no activities of de  novo pyrimidine-synthesis  enzymes were 
detected in  the  crude  extracts  of G.  lamblia.  This  finding,  which  suggests the 
absence of pyrimidine  de novo synthesis in  G.  lamblia,  agrees  with our recent 
observations on two other anaerobic,  flagellated protozoan  parasites,  Tritricho- 
monasfoetus (5) and  Trichomonas vaginalis  (6).  These two parasites are unable to 
synthesize pyrimidines de novo but rely on salvaging uracil  (5) or cytidine and 
uridine (6) for their requirement for pyrimidine ribonucleotides. They have no 
detectable dihydrofolate reductase or thymidylate synthetase activity; TMP can 
be only acquired via the action of a unique enzyme, thymidine phosphotransfer- 
ase,  for salvaging  exogenous thymidine.  Preliminary  studies  in  this  laboratory 
also indicated the absence of dihydrofolate reductase and thymidylate synthetase 
in  G.  lamblia  (Wang,  unpublished  results).  Tbymidine  salvage  by these  three 
parasites thus could be an attractive target for chemotherapeutic control of these 
three parasites. 
On  the  other  hand,  T. foetus  (7)  and  T.  vaginalis  (8)  have  also  been  found 
incapable of de novo synthesis ofpurine nucleotides, as would have been expected 
from the absence of dihydrofolate reductase. It is thus likely that G. lamblia may 
lack this synthetic capability.  In fact, all the protozoan parasites investigated to 
date appear to lack the activity in de novo purine synthesis and depend solely on 
purine  salvage  for  purine  nucleotides  (7-9).  This  common  deficiency among 
parasites  has provided ample opportunities  for chemotherapeutic  attack.  Allo- 
purinol is effective against Trypanosoma cruzi because the drug is recognized as a 
* Supported by National Institutes of Health Grant AI-19391. C. C. W. is a recipient of the 
Burroughs-Wellcome Molecular Parasitology  Award. 
J. ExP. MED. © The Rockefeller  University Press • 0022-1007/83/11/1703/10  $1.00  1703 
Volume 158  November  1983  t703-1712 1704  PURINE  SALVAGE  IN  GIARD1A  LAMBLIA 
substrate by the parasite hypoxanthine phosphoribosyl transferase (HPRT) ~ and 
is eventually incorporated into the parasite RNA (10). Allopurinol riboside (11) 
and formycin B (12) are effective antileishmanial  agents due to the presence of 
a  unique enzyme, purine nucleoside phosphotransferase, in the Leishmania  spp. 
that incorporates the compounds into the parasites.  T. foetus depends mainly on 
HPRT  (7), whereas T.  vaginalis relies solely on adenosine and guanosine kinase 
(8) for their needs for purine nucleotides. In recent studies (13), we were able to 
demonstrate that 8-azaguanine (inhibitor of HPRT), mycophenolic acid (inhibi- 
tor of I M P dehydrogenase), and hadacidin (inhibitor of succinyl AMP synthetase) 
were  inhibitors  of T. foetus  growth  without  affecting  T.  vaginalis.  Conversely, 
tubercidin, toyocamycin, sangivamycin, and araA, all known to inhibit adenosine 
kinase (13), exert significant inhibition only on the growth of T. vaginalis. 
It is the purpose of the present investigation to verify whether G.  lamblia  is 
indeed devoid of purine de novo synthesis and to delineate the entire network 
ofpurine salvage in G. lamblia as compared with those in T.foetus and T. vaginalis. 
Probable targets for chemotherapeutic control of G. lamblia and possible common 
targets in purine salvage among the three parasite species are explored. 
Materials and Methods 
G.  lamblia Cultures.  The G.  lamblia Portland I  strain was a  generous gift from Dr. 
Donald Lindmark of Cornell University. G. lamblia trophozoites were cultivated axenically 
in vitro under anaerobic conditions at 37°C in Diamond's BI-S-33 medium, pH 7.05 (14), 
with the following modifications: (a) sterilization of the medium was by filtration through 
a 0.22 #m Miilipore filter (Millipore/Continental Water Systems, Bedford, MA); (b) the 
vitamin-Tween 80 mixture was eliminated from the medium. Cultures reached stationary 
phase after 96 h of growth and had a final cell density of 2 ×  106/ml. These cultures were 
used to inoculate fresh media in a 2:10 ratio. Mid-log phase growth was achieved after 74 
h  incubation with a cell density of 106/ml.  These cells were harvested and used for all 
studies.  Cell  countings  were  routinely performed  in  a  Coulter  ZF  counter  (Coulter 
Electronics Inc., Hialeah, FL). 
Chemicals.  Radiolabeled glycine, formate, purines, and purine nucleosides were pur- 
chased from New England Nuclear, Boston, MA or ICN,  Irving, CA.  Formycin B was 
purchased from Sigma Chemical Co., St. Louis, MO. Mycophenolic acid was a gift from 
Dr. W.  Sadie of the School of Pharmacy, University of California, San  Francisco. All 
other chemicals used in the studies were of the highest purities commercially available. 
Precursor Incorporation into Nucleotide Pools.  G.  lamblia harvested by centrifugation at 
3,000 g for 5 min was washed three times and resuspended in phosphate-buffered saline 
glucose (20 mM), pH 7.0, with 2 mM cysteine, to a final cell density of 2 ×  107/ml, and 
incubated at 37°C. Radiolabeled substrates were each added to the cell suspension to a 
final concentration of 40 #M, and aliquots of 300 tA were taken at various time intervals. 
Each aliquot was treated with perchloric acid-KOH and filtered through glass fiber filters 
loaded with polyethyleneimine (PEI)-cellulose in 5  mM ammonium acetate, pH 5.0, as 
previously described (7). The nucleotide-loaded filter was washed with three 5-ml portions 
of the ammonium acetate buffer, dried, and soaked in Aquasol 2. Levels of radioactivity 
were determined with a Beckman LS-3133T liquid scintillation spectrometer (Beckman 
Instruments, Inc., Fullerton, CA). 
High Pressure Liquid Chromatography (HPLC).  Purine nucleotides were separated, iden- 
Abbreviations used in this paper."  APRT,  adenine phosphoribosyl transferase; GPRT,  guanine 
phosphoribosyl transferase; HPLC,  high pressure  liquid chromatography; HPRT, hypoxanthine 
phosphoribosyl  transferase;  PEI,  polyethyleneimine;  PRPP,  5-phosphoribosyl-l-pyrophosphate; 
TKMD, 25 mM Tris-HCl, pH 7.2, 20 mM KCI, 6 mM MgCl~, and  1 mM dithiothreitol; XPRT, 
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tiffed, and quantitated in an ion-exchange HPLC system with an Ultrasil AX (10 #m) 4.6 
x  250-mm column. Samples concentrated fivefold from the incorporation experiments 
(100 ~1) were injected and eluted with 7 mM phosphate buffer, pH 3.8, at a flow rate of 
1.0 ml/min. A programmed gradient elution from 7 mM phosphate buffer, pH 3.8, to 
250  mM  phosphate buffer, pH  4,5,  plus  500 mM  KCI was applied.  The effluent was 
monitored at 254 nm in a Beckman 160 UV-absorbance detector, mixed with Aquasol 2 
at a  1:3 ratio, and the radioactivity was recorded in a Flo-one radioactive flow detector 
(Radiomatic Instruments & Chemical Co., Inc., Tampa, FL). Both UV absorbance and 
radioactivity data were recorded and analyzed by a Hewlett-Packard 3390A integrator 
(Hewlett-Packard Co., Palo Alto, CA) (7). 
For the analysis ofpurine bases and nucleosides, a reverse-phase HPLC system with an 
ODS (5 ~m) reverse-phase column was used and eluted with a programmed gradient from 
7 mM KH2PO4, pH 6.0, to 50% acetonitrile at a flow rate of 0.75 ml/min. UV monitoring 
and continuous radioactivity measurement of the effluent were as previously described 
(7). 
Enzyme Assays.  Mid-log phase G. lamblia trophozoites were washed and resuspended in 
an equal volume of 25 mM Tris-HCI, pH  7.2,  20 mM KCI,  6  mM  MgCI2, and  1 mM 
dithiothreitol (TKMD). Cells  were disrupted using an  Ultrasonics sonicator (Ultrasonic 
Instruments International, Westbury, NY) in an ice bath for three 10-s pulses at an output 
setting of 4 and duty cycle setting of 40. The homogenate was centrifuged at 104 g for 30 
min to remove cell debris. The crude supernatant fraction was then centrifuged at 105g 
for 1 h to separate the soluble and pellet fractions. Protein concentrations were determined 
by the method of Bradford (15), with bovine serum albumin as the standard. 
Purine phosphoribosyl transferases were assayed according to a  modified procedure 
by Schmidt et al. (16). The reaction mixture, containing 100/~1 of 100 mM Tris-HC1, pH 
7.8, 8 mM MgCI2, 1.0 mM 5-phosphoribosyl-1-pyrophosphate  (PRPP), 50 ug • ml-' bovine 
14  1  14  serum albumin, and 20/~M of [8-  C]hypoxanthine (51.1 mCi • mmol- ), [8-  C]adenine 
(49.1  mCi • mmol-~), [8J4C]xanthine (41  mCi • mmol-l), or [8-~4C]guanine  (56.7 mCi • 
mmol  -~) was incubated at 37°C. The reaction, initiated by adding the enzyme sample, 
was terminated by adding an equal volume of ice-cold, 2 mM unlabeled purine solution. 
Aliquots of the mixture were filtered through PEI-cellulose and the trapped radioactivities 
were counted as described previously. 
Purine nucleoside kinases were assayed by a  procedure similar to that described by 
Nelson et ai. (I 1). The assay mixture, consisting of 100 mM Tris-HCl, pH 7.5, 20 mM 
ATP, 20 mM  MgCI2, 80 mM phosphoenolpyruvate, 40 IU • ml  -~  pyruvate kinase, and 
1.5  mM of [8-J4C]inosine  (12.0 mCi. mmol-l), [2,8-H3]adenosine (49.4 mCi. mmol-l), 
or [8-3H]guanosine (45.7  mCi. mmol-'), was  incubated at  37°C  for  10 min after the 
addition of  enzyme. The reaction was stopped by a 10-fold dilution of the reaction mixture 
in cold 5 mM ammonium acetate, pH 5.0. The PEI-adsorbable radioactivity was measured. 
Purine nucleoside phosphotransferases were assayed by using p-nitrophenylphosphate 
(10 raM) as the phosphate donor in an assay  mixture also consisting of 100  mM  Na- 
acetate, pH 5.4,  1.0 mM of the radiolabeled purine nucleosides, and the enzyme. Assay 
procedures were the same as for the kinases. 
Purine nucleoside hydrolase was assayed in TKMD with 1.0 mM [2,8-3H]adenosine (10 
mCi  •  mmo1-1) or [8-SH]guanosine (10 mCi • mmol-J).  Reactions were run at 37  C for 
varying lengths of time, terminated by perchloric acid, neutralized with KOH, and the 
reaction products were analyzed in reverse-phase HPLC to identify and quantitate the 
purine bases. 
Results 
Precursor Incorporation  into Nucleotide Pool.  [z4C]Formate (56.0 mCi • mmol-l), 
[2-3H]glycine (50.2  mCi.  mmoi-1),  [G-3H]hypoxanthine  (60.4  mCi.  mmol-l), 
[8-14C]xanthine  (41.0  mCi.  mmoi-I),  and  [8J4C]inosine  (55.0  mCi.  mmo1-1) 
were tested in the incorporation assay. All the substrates fell below the minimal 
level of detection for incorporation (0.80 pmol - 106 cells  -~) after 1 h incubation. 1706  PURINE  SALVAGE  IN  GIARDIA  LAMBLIA 
Radiolabeled  adenine,  adenosine,  guanine,  and  guanosine  were  all  able  to 
enter the nucleotide pool of G.  lamblia.  Data presented in  Fig.  1 indicate that 
adenine was incorporated at  the highest initial rate  of 3.5  pmol/min per  106 
cells. It was followed by adenosine (2.0 pmol • min  -1  • I0  s cells-~), guanine (1.5 
pmol - min  -~  •  106 cells-I), and guanosine (0.3 pmol • min  -~  • 106 cells-~). 
When the incorporation was carried out in the presence of another unlabeled 
substrate at  10-fold higher concentration,  the results presented in  Fig.  2  sug- 
gested highly specific competition among the four substrates: (a) Adenine incor- 
poration was only inhibited significantly by unlabeled adenine or adenosine (Fig. 
2A);  (b)  adenosine incorporation was  only inhibited significantly by unlabeled 
adenine or  adenosine  (Fig.  2B);  (c) guanine incorporation  was  only  inhibited 
significantly by unlabeled guanine or guanosine (Fig. 2 C);  (d) guanosine incor- 
poration was only inhibited significantly by unlabeled guanine or guanosine (Fig. 
2D).  It  is  clear  that  the  route  of adenine/adenosine  incorporation  into  the 
nucleotide pool of G.  lamblia  is well separated from that of guanine/guanosine 
incorporation. 
HPLC Analysis of the Radiolabeled  Nucleotide  Pool.  Pulse labeling of G.  lamblia 
trophozoites with [8-3H]adenine (Fig.  3A) and [2,8-3H]adenosine (Fig.  3B) for 
60 min resulted primarily in the labeling of AMP, ADP, ADP-hexose, and ATP 
in the nucleotide pool. There was no radioactivity detected in GMP,  GDP, or 
GTP. 
Similar experiments with [8-14C]guanine (Fig. 4A) and [8-~H]guanosine (Fig. 
I00 
-, 
~.  __._.___- 
~ 60 
O 
.~  40 
(~  2o 
0  I0  20  30  40  50  60  70 
Time  (min) 
FIGURE  1.  Incorporation  of radiolabeled  substrates  into  G.  lamblia  nucleotide  pool.  [8- 
$  1  3  1  14  H]Adenine  (64.4  mCi • mmol-)  (0);  [2,8- H]adenosine  (52.4  mCi - mmol- )  (O);  [8-  C]- 
guanine (54.67 mCi • mmol  -a) (I); [8-3H]guanosine (63.2 mCi • mmo1-1) (Fl). Each data value 
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FIGURE 2.  Inhibition of incorporation of radiolabeled substrates into G.  lamblia  nucleotide 
~HOOl by unlabeled substrates. The radiolabeled substrates are as described in Fig. 1. (A) [8- 
]adenine, (B) [2,8-SH]adenosine, (C) [SJ4C]guanine, (D) [8-SH]guanosine. The unlabeled 
substrates are each present at a concentration (400 gM) 10 times higher than the concentration 
of radiolabeled substrates. Adenine (O), adenosine (A), guanine (FI), guanosine (~7), none (0). 
Each data value was from three independent experiments. 
4B) as substrates resulted in heavy labeling of GMP, GDP, and GTP without any 
radioactivity  found  in  AMP,  ADP,  or  ATP.  However,  when  [5'-3H]guanosine 
was  used  as  the  substrate  for  pulse  labeling  (see  Fig.  4C),  only  3%  as  much 
radioactivity asthat from  [8-3H]guanosine was incorporated into the nucleotide 
pool. Of the little label in the pool, none was associated  with GDP or GTP,  but 
some was detected in AMP, ADP,  ATP,  ADP-hexose,  and GMP (Fig. 4C). 
These  data  clearly  indicate  that (a) adenine/adenosine  can  only be  incorpo- 
rated into adenine nucleotides; (b) guanine/guanosine can only be incorporated 1708  PURINE  SALVAGE IN  GIARDIA  LAMBLIA 
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FxcuRE  3.  HPLC analysis of G. /amb/ia  nucleotide pool pulse labeled by (A) [8-SH]adenine 
(25 Ci • mmol  -=) and (B) [2,8-3H]adenosine (48 Ci •mmol  -=) for 60 rain. 
into guanine nucleotides; (c) there is no interconversion between adenine nucleo- 
tide and guanine  nucleotide; (d) the ribose moiety of guanosine does not incor- 
porate with the guanine moiety, i.e., only guanine can be specifically incorporated 
into  guanine  nucleotides.  The  ribose  may have been  converted to  PRPP and 
become randomly incorporated into nucleotides. 
Enzyme Activities.  No purine nucleoside kinase or purine nucleoside phospho- 
transferase activity could be detected above the minimal level of 1 pmol • min -] • 
mg protein -1  in  the supernatant  and  105 g  pellet fractions of G.  lamblia  crude 
extracts.  Substantial  levels of adenine  phosphoribosyl transferase  and  guanine 
phosphoribosyl  transferase  (GPRT)  were,  however,  found  in  the  supernatant 
fraction  (see  Table  I).  But  HPRT  and  xanthine  phosphoribosyl  transferase 
(XPRT) were below the level of detection (see Table I). 
Among the other enzymic activities assayed, adenosine hydrolase and guano- 
sine  hydrolase  activities  were  detected  at  extraordinarily  high  levels  in  the 
supernatant  fraction  (Table  I).  These  activities,  hydrolyzing  adenosine  and 
guanosine to the corresponding purine bases, were not dependent on the pres- 
ence of orthophosphate.  They are thus not phosphorylases. 
Drug Sensitivity Test.  The inhibitor of IMP dehydrogenase, mycophenolic acid, 
which  blocks the  conversion  of IMP  to  XMP  and  GMP  (17),  was tested and 
titrated  in  the  in  vitro  culture  of G.  lamblia.  The  growth  of G.  lamblia  was 
unaffected up to 100 uM of the drug. 
Formycin  B,  a  nonhydrolyzable  purine  nucleoside  analog  (18)  whose  5'- 
monophosphate  derivative is known to block conversion of IMP to AMP (12), WANG  AND  ALDRITT  1709 
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FIC, UR~  4.  HPLC  analysis of G.  /amb/ia nucleodde pool pulse labeled b,7 (A) [8-~C]guanine 
(54.67 mCi • mmol-]), (B) [8-SH]guanosine (11.0 Ci • mmol-~), and (C) [5 -~H]guanosine (21.3 
Ci • mmol  -]) for 60 rain. 
Adenosine  C)  .  Adenine  ~  L  AMP~ADP~ATP 
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FIGURE 5.  The purine salvage pathways in G. lamblia.  (1) Adenosine hydrolase, (2) adenine 
phosphoribosyl transferase, (3) guanosine hydrolase, (4) guanine phosphoribosyl transferase. 
Numbers beneath the arrows represent specific  enzyme activities in nmol • rain-' •mg pro- 
tein  -l (see Table I). 
was also tested. No growth inhibition was observed up to  1 mM of formycin B 
in the medium. 
Discussion 
Our investigation has confirmed the absence of de nova purine synthesis in G. 
lamblia  by showing the failure of glycine and formate to enter the nucleotide 
pool. We have also revealed a remarkably simple scheme of purine salvage in G. 
lamblia that can be best presented in Fig. 5. 
The total lack of incorporation of hypoxanthine, inosine, and xanthine into G. 1710  PUR1NE  SALVAGE  IN  GIARDIA  LAMBLIA 
lamblia  nucleotides suggests the absence of HPRT and XPRT, which has been 
supported by the data from enzyme assays.  It also suggests the absence of IMP 
and the conversion of IMP to AMP and GMP in the parasite.  This suggestion 
has also been confirmed in the HPLC profiles by the total lack of interconversion 
between adenine nucleotides and guanine nucleotides. It is further supported by 
the insensitivity of G.  lamblia  toward mycophenolic acid and formycin B.  The 
competition  experiments  (Fig.  2)  and  the  HPLC  profiles  demonstrate  that 
adenine and adenosine are incorporated through  the same channel, and that 
they are converted only into adenine nucleotides. Guanine and guanosine are 
apparently incorporated by another route and they can only enter the guanine 
nucleotides. The HPLC profile in Fig. 4C further suggests that guanosine cannot 
be directly converted to  guanine nucleotides; it  has to  be  hydrolyzed first to 
guanine before the incorporation. Owing to the unavailability from commercial 
sources of adenosine with radiolabel only in the ribose moiety, we were unable 
to perform a  similar analysis on adenosine. But the enzyme profile has clearly 
demonstrated that G. lamblia  has no apparent means of directly salvaging either 
adenosine or guanosine.  The  most  likely mechanism of purine salvage in  the 
parasite is simply adenine salvage by adenine phosphoribosyl transferase (APRT) 
and  guanine  salvage by  GPRT  with  no  connection in  between (Fig.  5).  The 
presence of extraordinarily high adenosine hydrolase and guanosine hydrolase 
in  G.  lamblia  provides  added  proof to  this  simple  scheme of purine  salvage. 
Adenosine and  guanosine are apparently  rapidly hydrolyzed to  adenine and 
guanine before incorporation into AMP and GMP. 
This purine salvage network in  G.  lamblia  is not only simple but also totally 
different from those in T. foetus (7) and T.  z~aginalis (8).  These differences may 
provide many interesting subjects for future studies. Meanwhile, our own atten- 
tion for the immediate future will be centered on the GPRT of G.  lamblia.  It is 
apparently a very interesting enzyme since it does not recognize either hypoxan- 
thine or  xanthine as  substrate.  Since  HGPRT  activities usually reside in  one 
enzyme in  eukaryotes, and  since  XGPRT  activities are associated in  a  single 
enzyme in bacteria (19), the GPRT (or, less likely, AGPRT) in G.  lamblia  must 
have a somewhat different substrate specificity than its mammalian host HGPRT, 
TABLE  I 
Profile of Purine Salvage Enzymes in G. lamblia Trophozoites 
Specific activities* 
Enzymes  (nmol. min  -1 • mg protein -l) 
HPRT  <0.001 
GPRT  5.40 __+ 1.61 
XPRT  <0.001 
APRT  3.16 +  0.52 
Adenosine hydrolase 
Guanosine hydrolase 
967.7 +  32.4 
970.6 _+ 23.5 
* The activities  were  detected  in  the  10  5 g  supernatant fraction  of the  crude 
extract of G. lamblia trophozoites. Each data value was from three independent 
experiments. WANG  AND  ALDRITT  1711 
to allow specific inhibitor design. We believe that specific inhibition of G. lamblia 
GPRT will lead to effective chemotherapeutic control of the parasite. 
Summary 
Purine metabolism in Giardia  lamblia was investigated by monitoring incorpo- 
ration of radiolabeled precursors into purine nucleotides in the log-phase tro- 
phozoites cultivated in  vitro in  axenic media and incubated in buffered saline 
glucose. The lack of incorporation of formate, glycine, hypoxanthine, inosine, 
and xanthine into the nucleotide pool suggests the absence of de novo purine 
nucleotide synthesis and the inability to form IMP as the precursor of AMP and 
GMP  in  G.  lamblia.  Only  adenine,  adenosine,  guanine,  and  guanosine  were 
incorporated. Further analysis of the labeled nucleotides by HPLC indicated that 
adenine  and  adenosine  are  converted  only  to  adenine  nucleotides  whereas 
guanine and guanosine are only incorporated into guanine nucleotides. There is 
no competition of incorporation between adenine/adenosine and guanine/gua- 
nosine, and there is no interconversion between adenine and guanine nucleotides. 
Results from analyzing [5'-3H]guanosine incorporation indicate that the ribose 
moiety is  not  incorporated  with  the  guanine  base.  Assays  of purine  salvage 
enzymic activities in the crude extracts of G.  lamblia  revealed the presence of 
only four major enzymes; adenosine and guanosine hydrolases and adenine and 
guanine phosphoribosyl transferases. Apparently, G.  lamblia  has an exceedingly 
simple purine salvage system; it converts adenosine and guanosine to correspond- 
ing purine bases and then forms AMP and GMP by the actions of corresponding 
purine phosphoribosyl transferases. The guanine phosphoribosyl transferase in 
G.  lamblia  is  interesting because it does not recognize either hypoxanthine or 
xanthine as substrate.  It thus must have a  unique substrate specificity and may 
be regarded as a potential target to attack as a rational approach to chemother- 
apeutic control of giardiasis. 
Received  for publication  18July 1983. 
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